In addition to making testing more convenient and accessible through commercial laboratories, CDC will continue to work with state and local health departments to make the LRN process more efficient and reach out to health care providers and their state and local partners to learn more about monkeypox. CDC has worked with the LRN to augment the number of public health laboratories that can perform the test to over 67 laboratories across 48 states and the number of weekly tests available within the LRN to over 8,000 tests per week. CDC, in collaboration with the Food and Drug Administration (FDA), the Centers for Medicare & Medicaid Services, and the HHS Office of the Assistant Secretary for Preparedness and Response has also been expanding the capacity in the LRN. This expansion to commercial laboratories reflects the latest, most significant increase in capacity and accessibility, building on the capacities already available within the public health Laboratory Response Network (LRN). Since the first case was reported to the CDC on May 17, 2022, HHS has worked to increase testing capacity and accessibility. “By dramatically expanding the number of testing locations throughout the country, we are making it possible for anyone who needs to be tested to do so.”Īs of Tuesday, June 21 there have been 142 reported monkeypox cases in the United States across 24 states and Washington, D.C. Thankfully we have right now the tools to fight and treat cases in America,” said Health and Human Services Secretary Xavier Becerra. “All Americans should be concerned about monkeypox cases. ![]() This development will facilitate increased testing, leverage established relationships between clinics, hospitals and commercial laboratories, and support our ability to better understand the scope of the current monkeypox outbreak. Health care providers will be able to use these laboratories by early July and testing capacity through these companies will be ramped up throughout the month. These commercial laboratories will dramatically expand testing capacity nationwide and make testing more convenient and accessible for patients and health care providers. The companies include Aegis Science, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics and Sonic Healthcare. This week, the Department of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), began shipping orthopoxvirus tests to five commercial laboratory companies, including the nation’s largest reference laboratories, to quickly increase monkeypox testing capacity and access in every community during the ongoing monkeypox outbreak.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |